| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6487400 | Current Opinion in Biotechnology | 2016 | 7 Pages |
Abstract
- GAVI and its partners provide inexpensive vaccines to low-income countries.
- Various barriers exist to providing global accessibility to vaccines.
- Circumventing cold chain storage can reduce vaccine distribution costs.
- Improved antigens can reduce manufacturing costs and improve vaccine quality.
- New delivery platforms can improve vaccine administration outcomes.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Andrew B Hill, Christopher Kilgore, Margaret McGlynn, Charles H Jones,